Remembering the 22nd biennial Symposium 
of the International Immunocompromised 
Host Society, Basel, Switzerland, 
September 8 - 11, 2022


We thank the co-presidents, Hans H. Hirsch, MD and Mike Recher, MD, plus the respective Society Council members and the local scientific Committee for their dedication to making this congress a real success.

Infection and Immunity – Are You Competent?

 A Joint meeting of the International Immunocompromised Host Society ICHS (22nd Biennial Symposium) https://www.ichs.org/ and the Swiss Society of Allergy and Immunology SSAI (Annual Conference 2022)  https://ssai.ch/

     8.09.2022 – 11.09.2022 in Basel Switzerland



Meeting information, Abstract Submission and Registration:
https://ssai-ichs-jointmeeting.ch/

View the official program here. 

Please take a moment to preview the Basel meeting with this short video or access the promotional information sheet.


Check back often for meeting news and updates.

********************************************************************************************************

Conference Presidents

Hans H. Hirsch, Basel, Switzerland for the ICHS

Mike Recher, Basel, Switzerland, for the SSAI

 

Local Scientific Board

Christoph Berger, Basel

Daniela Finke, Basel

Luca Bernasconi, Aarau

Adrian Egli, Basel

Karin Hartmann, Basel

Ingmar Heijnen, Basel

Hans H. Hirsch, Basel

Nina Khanna, Basel

Karoline Leuzinger, Basel

Nicolas Müller, Zurich

Andri Rauch, Bern

Mike Recher, Basel

Federica Sallusto, Zurich

Roberto Speck, Zurich

Christian van Delden, Geneva

Jean Villard, Geneva

 

International Scientific Board

José-Maria Aguado, Spain

Murat Akova, Turkey

Robin Avery, USA

Roy Chemaly, USA

Tobias Hohl, USA

Thomas Lehrnbecher, Germany

Luis Ostrosky-Zeichner, USA

Monica Slavin, Australia

 

Topics

  • Primary immunodeficiency, acquired immunodeficiency, iatrogenic/therapeutic immunodeficiency, allergy, autoimmune disease
  • Infectious diseases, sepsis, intensive care, immune dysfunction
  • HIV/AIDS, leukemia, hematological and solid cancer chemo-/immunotherapy
  • Transplantation, acute rejection, chronic rejection, graft-versus-host disease
  • Clinical syndromes, diagnostic procedures, imaging studies
  • Antivirals, antibiotics, antifungals, antiparasitic drugs and integrated therapies
  • Vaccination, immune modulation, immunoglobulins, adoptive immune cell therapy
  • Translational virology, mycology, bacteriology, parasitology, immunology

Confirmed Speakers

José-Maria Aguado, (Madrid, Spain)

Murat Akova, (Ankara, Turkey)

Robin Avery, (Baltimore, MD, USA)

Lindsey Baden, (Boston, MA, USA)

Pierre-Yves Bochud, (Lausanne, Switzerland)

Jens Bremerich, (Basel, Switzerland)

Jean-Laurent Casanova, (New York, USA) & (Paris, France)

Thierry Calandra, (Lausanne Switzerland)

Roy Chemaly, (Houston, TX, USA)

Patrizia Comoli, (Pavia, Italy)

Sanjeet Dadhwal, (City of Hope, CA, USA)

Christine Durand, (Baltimore, MD, USA)

Adrian Egli, (Basel, Switzerland)

Stephan Ehl, (Freiburg, Germany)

Mario Fernandez-Ruiz, (Madrid, Spain)

Jay A. Fishman, (Boston, MA, USA)

Dela Golshayan, (Lausanne, Switzerland)

Paolo Grossi, (Varese, Italy)

Natasha Halasa (Nashville, TN, USA)

Marcus Heim (Basel, Switzerland)

Christoph Hess, (Cambridge, UK) & (Basel, Switzerland)

Tobias Hohl, (New York, USA)

Steven Holland, (Bethesda, MD, (NIAID), USA)

Eddie Holmes, (Melbourne, Australia)

Mike Ison, (Chicago, IL, USA)

Nassim Kamar, (Toulouse, France)

Nina Khanna, (Basel, Switzerland)

Camile Kotton, (Boston, MA, USA)

Thomas Lehrnbecher, (Frankfurt, DER)

Per Ljungman, (Stockholm, Sweden)

Alexandre Loupy, (Paris, France)

Jens Lundgren, (Copenhagen, Denmark)

Johann Maertens, (Leiden, Belgium)

Georg Maschmeyer, (Berlin, Germany)

Malgorzata Milkulska, (Genoa, Italy)

Josh Milner, (Bethesda, MD (NIH), USA)

Darius Moradpour, (Lausanne, Switzerland)

Zenia Papanicolaou, (New York, USA)

Steven Pergam, (Seattle, WA, USA)

Francesco R. Simonetti, (Baltimore, MD, USA)

Monica Slavin, (Melbourne, Australia)

Marie von Lilienfeld-Toal, (Jena, Germany)

Rolf Zinkernagel, (Zurich, Switzerland)

 

Formats

Plenary sessions, parallel sessions, meet-the-expert sessions, pro & con debate, case presentation, panel arena, abstract sessions, posters and poster walks, industry symposia industry lunch symposia, industry exhibition, networking opportunities, late-breaker, awards.


Supporting Societies

ESCMID, ESCMID Study group Immunocompromised Hosts (ESGICH), ESCMID Study group for Respiratory Viruses (ESGREV), SSAI, SSID.


Supporting Organizations and Institutions

City of Basel, University Hospital Basel, University of Basel, NIH.

*****************************************************************************************

The 22nd ICHS Symposium has concluded.

Thank you again for attending the 22nd ICHS Symposium on Infections in the Immunocompromised Host. We hope you had an enjoyable experience and have come away with new knowledge and network opportunities.

Coming Soon:

Please review the winners of the Lifetime Achievement Award and the Young investigator Awards, as well as awards for best abstracts and posters.  These presentations were made during the Basel meeting.

Coming soon:

A reminder that presentation recordings of the ICHS sessions will be available to all members via the ICHS website, using the normal login information.




© International Immunocompromised Host Society
Powered by Wild Apricot Membership Software